This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a bromine atom and a tetrahydroimidazopyrazine core, makes it a valuable building block for creating compounds that target specific receptors or enzymes in the body. It is often employed in the design of potential therapeutic agents for neurological disorders, including anxiety and depression, due to its ability to interact with neurotransmitter systems. Additionally, its reactivity allows for further chemical modifications, enabling the exploration of novel drug candidates in medicinal chemistry.